GOODRX HOLDINGS INC. CL.A

GoodRx introduced Companion, a family healthcare subscription that provides free access to 250 generic medications and discounted telehealth, vision, dental and lab services for $24.99 per month (individual plan $14.99). The company plans to make Companion available as an employer-offered benefit starting January 1, 2027, with employers able to subsidize employee costs. GoodRx reported 39% year-over-year growth in subscription revenue in Q2 and said Companion uptake has exceeded expectations. » Więcej na finance.yahoo.com

At the GoodRx annual meeting, shareholders voted to elect class‑III directors Wendy Barnes, Ronald E. Bruehlman and Gregory Mondre and to appoint KPMG as independent auditors for fiscal year 2026. In a non‑binding vote, shareholders also approved the performance‑based compensation for the named executives. GoodRx reported Q1 2026 EPS of $0.07 (plan met) and revenue of $194 million (4.7% above expectations) and introduced a monthly subscription offering, "GoodRx Companion," for $14.99. » Więcej na de.investing.com

GoodRx introduced Companion, a $14.99/month subscription aimed at patients with chronic conditions that combines savings on more than 200 common generic medications with discounted dental services and $19 telehealth visits for routine issues. The service expands GoodRx’s subscription strategy and creates a more predictable recurring revenue stream by engaging consumers beyond one-off prescription transactions. Companion also offers lower-cost access to exams, cleanings, X-rays and other dental care. » Więcej na finance.yahoo.com